We are live on !
Find out more
CE
Clark Estates Portfolio holdings
AUM
$430M
Turnover
31.13%
1-Year Est. Return
9.71%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+9.71%
3 Year Est. Return
+47.82%
5 Year Est. Return
+44.64%
10 Year Est. Return
+195.24%
AUM
$434M
AUM Growth
+$17.5M
(+4.2%)
Cap. Flow
-$3.16M
Cap. Flow % of AUM
Cap. Flow %
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18
Avg Time Held
2.5
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$25.8M |
| 2 |
Henry Schein
HSIC
|
+$9.7M |
| 3 |
Unilever
UL
|
+$3.76M |
| 4 |
Best Buy
BBY
|
+$2.9M |
| 5 |
Sony
SONY
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euclidean Fundamental Value ETF
ECML
|
+$15M |
| 2 |
Avanos Medical
AVNS
|
+$11.8M |
| 3 |
IQVIA
IQV
|
+$7.5M |
| 4 |
Solventum
SOLV
|
+$6.56M |
| 5 |
Medtronic
MDT
|
+$5.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.82% |
| 2 | Miscellaneous | 21.8% |
| 3 | Technology | 13.51% |
| 4 | Communication Services | 11.78% |
| 5 | Consumer Staples | 7.78% |
Similar funds
CWM
MCM
Clark Estates's Q2 2026 Portfolio in Review
As of Q2 2026, Clark Estates held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Clark Estates's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.
- Clark Estates's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
- Clark Estates added most to Henry Schein in Q2 2026, an estimated $9.7M increase.
- Clark Estates's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
- Clark Estates fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
- Clark Estates's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
- Clark Estates opened 11 new positions and closed 18 in Q2 2026.
- Clark Estates's portfolio value rose 4.2% quarter-over-quarter to $434M.
Based on Clark Estates's 13F filing for Q2 2026, filed 5 Aug 2026.